Get the Stockscreener App
1.075
1.42%
0.015
Inmed Pharmaceuticals Inc stock is traded at $1.075, with a volume of 5,388.
It is up +1.42% in the last 24 hours and down -18.56% over the past month.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
See More
Previous Close:
$1.06
Open:
$1.06
24h Volume:
5,388
Relative Volume:
0.02
Market Cap:
$3.03M
Revenue:
$4.96M
Net Income/Loss:
$-6.82M
P/E Ratio:
-0.0164
EPS:
-65.4
Net Cash Flow:
$-6.64M
1W Performance:
-11.89%
1M Performance:
-18.56%
6M Performance:
-64.75%
1Y Performance:
-77.60%
1-Day Range:
$1.055
$1.08
1-Week Range:
$1.03
$1.24
52-Week Range:
$1.03
$8.27
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
Name
Inmed Pharmaceuticals Inc
Sector
Phone
(604) 669-7207
Address
1445-885 WEST GEORGIA ST., VANCOUVER
Compare INM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INM
Inmed Pharmaceuticals Inc
|
1.08 | 2.97M | 4.96M | -6.82M | -6.64M | -65.40 |
|
ZTS
Zoetis Inc
|
125.17 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.61 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.03 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.96 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
485.41 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Inmed Pharmaceuticals Inc Stock (INM) Latest News
InMed Pharmaceuticals (NASDAQ:INM) Trading Up 5% – Time to Buy? - Defense World
Indian Infotech and Software Limited At Critical Juncture Bounce or BreakdownGlobal Trade Effects & Budget Friendly Portfolio Growth - earlytimes.in
InMed faces challenges from new US legislation - MSN
What dividend safety score for InMed Pharmaceuticals Inc. stockJuly 2025 Highlights & Real-Time Volume Trigger Notifications - Улправда
Risk Check: Can InMed Pharmaceuticals Inc. stock outperform in 2025 bull market - Улправда
Surprises Report: What Wall Street predicts for InMed Pharmaceuticals Inc. stock price2025 Momentum Check & Advanced Technical Analysis Signals - Улправда
Growth Value: Why hedge funds are buying InMed Pharmaceuticals Inc. stock2025 Bull vs Bear & Real-Time Price Movement Reports - Улправда
Can InMed Pharmaceuticals Inc. stock outperform in 2025 bull marketQuarterly Market Summary & Stepwise Trade Signal Implementation - Улправда
Day Trade: How analysts revise price targets for InMed Pharmaceuticals Inc. (MWG) stockJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - Улправда
Why hedge funds are buying InMed Pharmaceuticals Inc. stockJuly 2025 Trends & Stepwise Entry and Exit Trade Signals - Улправда
InMed Shareholders Approve Directors and Equity Financing Flexibility - TipRanks
InMed Pharmaceuticals (INM) investors approve directors, auditor and 20%+ SEPA share issuance - Stock Titan
InMed Announces Results of 2025 Annual General and Special Meeting - Investing News Network
Drug developer's investors sign off on potential 20% new share issuance - Stock Titan
InMed Pharmaceuticals (INM) director details employee stock option expiry - Stock Titan
InMed Pharmaceuticals (INM) CEO Eric Adams details 250-option expiry - Stock Titan
InMed Pharmaceuticals Inc. (INM) discloses COO stock option expiration - Stock Titan
InMed Pharmaceuticals (INM) reports senior VP employee option expiration - Stock Titan
InMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ET - TMX Newsfile
InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025 - TMX Newsfile
Dated alerts on InMed Pharmaceuticals withdrawn - marketscreener.com
InMed Faces Challenges from New U.S. Legislation - TipRanks
InMed Pharmaceuticals Inc Evaluates Impact of New US Legislation on Subsidiary - TradingView — Track All Markets
InMed Pharmaceuticals (NASDAQ: INM) files update on H.R. 5371 impact - Stock Titan
Aquestive Therapeutics (NASDAQ:AQST) and InMed Pharmaceuticals (NASDAQ:INM) Head to Head Comparison - Defense World
InMed Provides Update on BayMedica Commercial Business - TMX Newsfile
Life Sciences Virtual Investor Forum Agenda Announced for December 11th - The Manila Times
Analysis Recap: Why hedge funds are buying InMed Pharmaceuticals Inc stockJuly 2025 Momentum & Community Consensus Trade Signals - BỘ NỘI VỤ
What insider trading reveals about InMed Pharmaceuticals Inc. stock2025 Stock Rankings & Expert Approved Momentum Ideas - Newser
Why InMed Pharmaceuticals Inc. (MWG) stock attracts HNW investorsMarket Growth Report & Expert Approved Momentum Trade Ideas - Newser
Is InMed Pharmaceuticals Inc. (MWG) stock worth buying before Fed actionShare Buyback & AI Powered Market Entry Ideas - Newser
Is InMed Pharmaceuticals Inc. (MWG) stock considered safe havenDollar Strength & High Conviction Investment Ideas - Newser
InMed Pharmaceuticals Inc. (INM) AI-Powered Stock Analysis - Meyka
Why pension funds invest in InMed Pharmaceuticals Inc. (MWG) stock2025 Risk Factors & Reliable Momentum Entry Alerts - Newser
Will InMed Pharmaceuticals Inc. (MWG) stock rise with strong economyWeekly Volume Report & Verified Stock Trade Ideas - Newser
Financial Comparison: InMed Pharmaceuticals (NASDAQ:INM) & Avalo Therapeutics (NASDAQ:AVTX) - Defense World
InMed Pharmaceuticals (INM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is InMed Pharmaceuticals Inc. (MWG) stock a top hedge fund pick2025 Price Targets & Smart Swing Trading Techniques - Newser
Will New Partnerships Boost Dhampur Sugar Mills Limiteds OutlookInsider Trading Compliance & Small Investment Portfolio - earlytimes.in
How InMed Pharmaceuticals Inc. stock performs in weak economyJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Will InMed Pharmaceuticals Inc. (MWG) stock remain on Wall Street radarPrice Action & Real-Time Volume Trigger Notifications - Newser
Is InMed Pharmaceuticals Inc. (MWG) stock a good hedge against inflation2025 Technical Overview & Advanced Technical Analysis Signals - Newser
What market sentiment indicators show for InMed Pharmaceuticals Inc. (MWG) stockWeekly Stock Summary & Expert Curated Trade Setup Alerts - Newser
Is InMed Pharmaceuticals Inc MWG a good long term investmentStock Price Targets & Budget Friendly Investment Plans - earlytimes.in
Inmed Pharmaceuticals Inc Stock (INM) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.48%
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):